Not available
Quote | PTC Therapeutics Inc. (NASDAQ:PTCT)
Last: | $30.93 |
---|---|
Change Percent: | 0.32% |
Open: | $30.9 |
Close: | $30.93 |
High: | $31.2 |
Low: | $30.145 |
Volume: | 519,404 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | PTC Therapeutics Inc. (NASDAQ:PTCT)
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
2024-06-28 07:10:33 ET More on PTC Therapeutics PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript PTC The...
Message Board Posts | PTC Therapeutics Inc. (NASDAQ:PTCT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PTCT News Article - PTC Therapeutics Provides an Update on Commercial Progress and R&D | whytestocks | investorshangout | 01/09/2023 6:41:00 PM |
whytestocks: $PTCT News Article - Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC | whytestocks | investorshangout | 11/17/2022 6:30:53 PM |
whytestocks: $PTCT News Article - PTC Therapeutics' 2022 STRIVE Awards Program Funds Initiatives Sup | whytestocks | investorshangout | 09/07/2022 6:21:01 PM |
whytestocks: $PTCT News Article - PTC Therapeutics Provides an Update on Commercial Progress and R&D | whytestocks | investorshangout | 01/10/2022 5:30:49 PM |
Power hour $PTCT let go | DayTraderOG | investorshub | 05/04/2021 6:52:48 PM |
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review PR Newswire - PTC to submit a request for re-examination - WARREN, N.J. , June 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announce...
Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients PR Newswire - FDA lifts PTC518 partial clinical hold based on PIVOT-HD data - - Conference call and webcast to be held ...
2024-06-14 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...